ES2184650B1 - USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. - Google Patents
USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS.Info
- Publication number
- ES2184650B1 ES2184650B1 ES200102260A ES200102260A ES2184650B1 ES 2184650 B1 ES2184650 B1 ES 2184650B1 ES 200102260 A ES200102260 A ES 200102260A ES 200102260 A ES200102260 A ES 200102260A ES 2184650 B1 ES2184650 B1 ES 2184650B1
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- cholesterol
- leishmaniasis
- phospholipids
- canidos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
Utilización de colesterol y fosfolípidos en medicamentos para el tratamiento de la leishmaniasis en los cánidos. Se describe la utilización combinada del colesterol y la fosfatidilserina en la fabricación de medicamentos para el tratamiento de la leishmaniasis canina. Dicha combinación resulta eficaz por sí sola en el tratamiento de los animales afectados por la mencionada enfermedad y además, cuando se utiliza de forma combinada con otros tratamientos convencionales, especialmente con compuestos antimoniales y alopurinol, resulta ser altamente efectiva.Use of cholesterol and phospholipids in medications for the treatment of leishmaniasis in canids. The combined use of cholesterol and phosphatidylserine in the manufacture of medicaments for the treatment of canine leishmaniasis is described. This combination is effective in itself in the treatment of animals affected by the aforementioned disease and also, when used in combination with other conventional treatments, especially with antimonial compounds and allopurinol, it is highly effective.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200102260A ES2184650B1 (en) | 2001-10-10 | 2001-10-10 | USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200102260A ES2184650B1 (en) | 2001-10-10 | 2001-10-10 | USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2184650A1 ES2184650A1 (en) | 2003-04-01 |
ES2184650B1 true ES2184650B1 (en) | 2004-09-16 |
Family
ID=8499152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200102260A Expired - Fee Related ES2184650B1 (en) | 2001-10-10 | 2001-10-10 | USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2184650B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302459A (en) * | 1980-03-19 | 1981-11-24 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives |
PT1019417E (en) * | 1997-08-18 | 2003-03-31 | Max Planck Ges Zur Forderung W | PHOSPHOLIPID ANALYSIS COMPOUNDS |
DE10015814A1 (en) * | 2000-03-30 | 2001-10-11 | Max Planck Gesellschaft | Medicines to stimulate leukopoiesis, treat tumors and protozoan diseases and process for its manufacture |
-
2001
- 2001-10-10 ES ES200102260A patent/ES2184650B1/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
ALVING, C.R. et al.: "Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs", P.N.A.S. U.S.A. (1978), 75 (6), páginas 2959-63, ISSN: 0027-8424, todo el documento. * |
Also Published As
Publication number | Publication date |
---|---|
ES2184650A1 (en) | 2003-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR122014006936B8 (en) | pharmaceutical composition comprising in the form of an intravaginal ring | |
UY28757A1 (en) | SUBSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS | |
UY27511A1 (en) | NEW ANDIDIABÉTIC AGENTS | |
ITPD20020246A1 (en) | STRUCTURE OF WATERPROOF AND BREATHABLE SOLE FOR FOOTWEAR AND FOOTWEAR MADE WITH THE SOLE. | |
ECSP055747A (en) | CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS | |
AR037109A1 (en) | USE OF FLIBANSERINE | |
BRPI0308360B8 (en) | thermosensitive composition in liquid form comprising organogelling substance, use of a composition and process for preparing a composition | |
GT200200188A (en) | PREPARATION AND USE OF IMIDAZOL DERIVATIVES FOR THE TREATMENT OF OBESITY | |
GT199900203A (en) | CELECOXIB COMPOSITIONS. | |
CY1110019T1 (en) | Combined Therapy with Substituted Oxazolidinones | |
UY28040A1 (en) | CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS. | |
CL2003002767A1 (en) | ORAL COMPOSITION THAT INCLUDES A FILM CONTAINING A FUNCTIONAL MATERIAL, IN A VEHICLE, USEFUL FOR ORAL CARE. | |
BR9910490A (en) | Materials and methods for creating insects, mites and other beneficial organisms | |
MX9307885A (en) | APPLICATION OF CARBAMZAEPINE AND OXCARBAZEPIAN TO OBTAIN MEDICINES FOR THE TREATMENT OF PARKINSON DISEASE AND PARKINSONIAN SYNDROMES. | |
ECSP045353A (en) | DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND APPLICATION AS MEDICATIONS | |
BRPI0415713A (en) | myo-inositol hexaphosphate for topical use | |
BR0107628A (en) | 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation | |
DE602006009259D1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL | |
ATE413399T1 (en) | MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATORY PROCESSES | |
DK1713438T3 (en) | Medical soap | |
ES2184650B1 (en) | USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. | |
AR036877A1 (en) | PHARMACEUTICAL FORMULATION | |
CO5261531A1 (en) | PLEUROMUTILINE AND VALNEMULIN DERIVATIVES USED FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TRANSDERMAL TREATMENT OF BACTERIAL INFECTIONS IN HUMANS AND ANIMALS AND COMPOSITION CONTAINING THEM | |
BR0210632A (en) | Parasitic disease treatment | |
RU2002107079A (en) | Sedative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20030401 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2184650B1 Country of ref document: ES |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180807 |